Incorporating Robust Endpoints in Clinical Trials through Careful Trial Design for Treatment Response Assessment
Time: 2:30 pm
day: Day One Track B PM
Details:
• Addressing phase I-III design strategy that integrates liquid biopsy
• Discussing the clinical utility of different endpoints in trials
• Understanding how endpoints enable patient stratification
• Examining the impact of having robust endpoints on treatment response options and decisions
